Home » Newsletters » BioWorld

BioWorld

March 1, 1995

View Archived Issues

LA JOLLA LAUNCHES PHASE II STUDIES OF LUPUS DRUG FOR KIDNEY DISEASE

NOBEL LAUREATES PLEAD FOR NIH'S BUDGET

HOECHST MAKES $7B OFFER TO ACQUIRE MARION MERRELL DOW

OTHER NEWS TO NOTE

SCOPING DIABETES SUSCEPTIBILITY GENES YIELDS SOME ANSWERS, MORE

VERTEX, WELLCOME TAKE PROTEASE INHIBITOR INTO CLINIC

HOUSE LIKELY TO PASS RISK ASSESSMENT BILL

AMGEN TO PAY UP TO $90M FOR OBESITY GENE

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 9, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026